Form 4 for MAS Masco
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001225208-26-001946 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-17 | 2026-02-12 | MAS | Cole Kenneth G. | VP, GC, Sec | A - Grant | $0.00 | +13.6K | 91.5K | +17% | $0 |
| D | 2026-02-17 | 2026-02-12 | MAS | Cole Kenneth G. | VP, GC, Sec | F - Tax | $77.54 | -2,589 | 93.3K | -3% | -$200.8K |
| DM | 2026-02-17 | 2026-02-12 | MAS | Cole Kenneth G. | VP, GC, Sec | M - OptEx | $37.64 | +51.9K | 58.2K | +830% | +$1.95M |
| DM | 2026-02-17 | 2026-02-12 | MAS | Cole Kenneth G. | VP, GC, Sec | S - Sale+OE | $77.03 | -51.9K | 69.2K | -43% | -$4.00M |
| D | 2026-02-17 | 2026-02-12 | MAS | Cole Kenneth G. | VP, GC, Sec | A - Grant | — | +13.5K | 13.5K | New | — |
| DM | 2026-02-17 | 2026-02-12 | MAS | Cole Kenneth G. | VP, GC, Sec | M - OptEx | — | -51.9K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | A | A | 4,310 | $0.00 | 95,860 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-12 | F | D | 2,589 | $77.54 | 93,271 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-12 | A | A | 9,285 | $0.00 | 91,550 | D | — | — | (F1) Shares reported in this column represent shares awarded in connection with the vesting of performance stock units awarded in 2023, as certified by the Compensation and Talent Committee on February 6, 2026. |
| 4 | Common | Common Stock | 2026-02-12 | M | A | 24,110 | $42.13 | 82,265 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-12 | M | A | 27,790 | $33.75 | 58,155 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-12 | S | D | 27,790 | $77.06 | 41,371 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $77.08, inclusive. |
| 7 | Common | Common Stock | 2026-02-12 | S | D | 24,110 | $77.00 | 69,161 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.00 to $77.01, inclusive. The reporting person undertakes to provide to Masco Corporation, any security holder of Masco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. |
| 8 | Derivative | Employee Stock Option | 2026-02-12 | A | A | 13,520 | — | 13,520 | D | $77.54 · — to 2036-02-12 | 13,520 Common Stock | (F9) Grant of option under the Masco Corporation 2024 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F8) This option is exercisable in three approximately equal annual installments commencing February 12, 2027. |
| 9 | Derivative | Employee Stock Option | 2026-02-12 | M | D | 24,110 | — | 0 | D | $42.13 · — to 2028-02-09 | 24,110 Common Stock | (F6) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F5) This option became exercisable in five equal annual installments commencing February 9, 2019. |
| 10 | Derivative | Employee Stock Option | 2026-02-12 | M | D | 27,790 | — | 0 | D | $33.75 · — to 2027-02-10 | 27,790 Common Stock | (F6) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F7) This option became exercisable in five equal annual installments commencing February 10, 2018. |